Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Recipient : GigaMune
Deal Size : Undisclosed
Deal Type : Partnership
Details : Under the terms of the agreement, Champions will have the right to select a specified number of TCRs from the library for further, wholly owned, development. The remaining libraries will be jointly owned by Champions and GigaMune for commercialization, w...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 15, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Recipient : GigaMune
Deal Size : Undisclosed
Deal Type : Partnership